OHM FLU

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: OHM FLU
Generic name: ANAS BARBARIAE, HEPATIS ET CORDIS EXTRACTUM, INFLUENZINUM
Manufacturer: OHM PHARMA INC.
Product type: HUMAN OTC DRUG
SPL set ID: e5804d17-5ff8-459d-9b94-de2134930201
SPL ID: d44b1652-5ba4-2927-e053-2a95a90a48f9
Version: 4
Effective date: 2021-12-29
Source export date: 2026-09-28
Source partition: 10
Source file: https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/4bbc9760f647649b787710953d978bd6419e899ba8b90f32c3d972aae43947f8/drug-label-0010-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:09:36

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		OHM FLU	openfda.brand_name
generic name		ANAS BARBARIAE, HEPATIS ET CORDIS EXTRACTUM, INFLUENZINUM	openfda.generic_name
manufacturer name		OHM PHARMA INC.	openfda.manufacturer_name
ndc	package	66096-170-06	openfda.package_ndc
ndc	product	66096-170	openfda.product_ndc
ndc11	package	66096017006	derived:openfda.package_ndc
spl id		d44b1652-5ba4-2927-e053-2a95a90a48f9	id
spl set id		e5804d17-5ff8-459d-9b94-de2134930201	set_id
unii		R9HH0NDE2E	openfda.unii
unii		1314JZ2X6W	openfda.unii
unii		RN2HC612GY	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS: IF PREGNANT OR BREAST-FEEDING, ask a health professional before use. If symptoms persist for more than 3 days, discontinue use and contact a health professional. This product is not intended to be an alternative to vaccination. KEEP OUT OF THE REACH OF CHILDREN.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.